{
    "Trade/Device Name(s)": [
        "N Latex FLC kappa assay",
        "N Latex FLC lambda assay",
        "N FLC Standard SL",
        "N FLC Control SL1",
        "N FLC Control SL2",
        "N FLC Supplementary Reagent"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products GmbH",
    "510(k) Number": "K171742",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031016"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DFH",
        "DEH",
        "JIX",
        "JJY"
    ],
    "Summary Letter Date": "October 19, 2017",
    "Summary Letter Received Date": "October 20, 2017",
    "Submission Date": "November 14, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.5550",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Immunoglobulin (light chain specific) immunological test system",
        "Calibrator, Multi-Analyte Mixture",
        "Multi-Analyte Controls"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Free light chains kappa",
        "Free light chains lambda"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BN II",
        "BN ProSpec"
    ],
    "Method(s)/Technology(ies)": [
        "Particle-enhanced immunonephelometry"
    ],
    "Methodologies": [
        "Immunonephelometry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens N Latex FLC kappa and lambda assays, calibrator, and controls using immunonephelometry to measure serum/plasma free light chains for multiple myeloma and amyloidosis diagnosis",
    "Indications for Use Summary": "Quantitative determination of free light chains (kappa or lambda) in human serum and EDTA plasma by immunonephelometry on BN Systems as an aid in diagnosis of multiple myeloma and amyloidosis",
    "fda_folder": "Immunology"
}